Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could this pill slow Parkinson's? new trial results are in

NCT ID NCT06329141

First seen May 23, 2026 · Last updated May 23, 2026

Summary

This study tested an experimental drug called vutiglabridin in 99 people with early Parkinson's disease. Participants took either the drug or a placebo daily for 24 weeks. Researchers measured changes in movement, daily function, and safety to see if the drug could help control the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Hallym University Medical Center

    Anyang-si, Gyeonggi-do, 14068, South Korea

  • Inje University Busan Paik Hospital

    Busan, 47392, South Korea

  • Inje University Sanggye Paik Hospital

    Seoul, 01757, South Korea

  • Korea University Guro Hospital

    Seoul, 08308, South Korea

  • KyungHee University Medical Center

    Seoul, 02447, South Korea

  • Samsung Medical Center

    Seoul, 06351, South Korea

  • Severance Hospital

    Seoul, 03722, South Korea

  • The Catholic University of Korea

    Seoul, 06591, South Korea

  • The Catholic University of Korea Uijeongbu St.Marys Hostpial

    Uijeongbu-si, Gyeonggi-do, 11765, South Korea

Conditions

Explore the condition pages connected to this study.